<SEC-DOCUMENT>0001764013-22-000068-index.html : 20220630
<SEC-HEADER>0001764013-22-000068.hdr.sgml : 20220630
<ACCEPTANCE-DATETIME>20220630071507
ACCESSION NUMBER:		0001764013-22-000068
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220630
DATE AS OF CHANGE:		20220630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immunovant, Inc.
		CENTRAL INDEX KEY:			0001764013
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				832771572
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38906
		FILM NUMBER:		221056493

	BUSINESS ADDRESS:	
		STREET 1:		320 WEST 37TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		917-580-3099

	MAIL ADDRESS:	
		STREET 1:		320 WEST 37TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Health Sciences Acquisitions Corp
		DATE OF NAME CHANGE:	20190108
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14acoverpage-3x31x22.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: defa14acoverpage-3x31x22.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>immunovantinc_vsmvxnaxp747a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: immunovantinc_vsmvxnaxp747a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>immunovantinc_vsmvxnaxp747.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: immunovantinc_vsmvxnaxp747.jpg

</DOCUMENT>
</SEC-DOCUMENT>